• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review

Corresponding author: ZHU He, he.zhu@pku.edu.cn
DOI: 10.12201/bmr.202303.00033
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Objective: To evaluate the impact of the national centralized drug procurement policy on drug prices and utilization. Methods: A systematic review approach was applied to search six databases: China Knowledge Network (CNKI), WanFang (WanFang Data), Vipshop (VIP), EMbase, PubMed, and Web of Science, and empirical findings were extracted and analyzed. Results: A total of 58 studies were included, and most of them found a significant decrease in the defined daily cost (DDC) of the selected drugs after the implementation of the national centralized drug procurement policy, as well as a decrease in similar nonselected drugs’s DDC. For example, hepatitis drugs’ DDC showed a significant decrease. The Defined daily doses (DDDs) of generic drugs increased significantly overall, achieving partial domestic substitution for the original drugs. For example, DDDs of most drugs related to cardiovascular diseases increased significantly. However, there were some regional differences in the implementation effect of the national centralized drug procurement policy and the phenomenon of price decoupling, which need to be further strengthened and improved. Conclusion: According to previously empirical findings of policy effects, the policy goals have been achieved initially, and it is recommended to continue to work on promoting the equalization of low-priced and high-quality drugs and increasing the policy publicity and the monitor of drug quality and price.

    Key words: National Centralized Drug Procurement Policy;Defined daily doses (DDDs);Defined daily cost (DDC); Systematic review; ; 

    Submit time: 23 March 2023

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • ZHU yan, ZHENG Jie, Li Xiaoying, Yang Xiaolin, HE Yongqun. Introduction to Basic Formal Ontology and its Chinese Translation. 2020. doi: 10.12201/bmr.202007.00009

    Tang Yuqing, Li Yinming, Chen Xizhuo, Xue Tianqin, Chen Hao. Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model. 2023. doi: 10.12201/bmr.202310.00002

    WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

    Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

    LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

    WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

    LI Zhao, Zhao Ke, Zhou Lulin, Chen Sheng. Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement. 2021. doi: 10.12201/bmr.202109.00037

    Li Hong-yu, Sun Qiang. Analysis of the impact of the Two Ballot System policy on drug supply in Shandong province. 2021. doi: 10.12201/bmr.202011.00015

    songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

    HAN Meng, WANG Shi-jia, HU Hao-yu, ZHAO Yan-jiao, CHEN Yong-fa. Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine. 2023. doi: 10.12201/bmr.202312.00008

  • ID Submit time Number Download
    1 2022-10-10

    bmr.202303.00033V1

    Download
  • Public  Anonymous  To author only

Get Citation

SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. biomedRxiv.202303.00033

Article Metrics

  • Read: 460
  • Download: 2
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误